- Home
- SPIR vs IMAB Comparison
SPIR vs IMAB Comparison
Compare SPIR & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPIR
- IMAB
- Stock Information
- Founded
- SPIR 2012
- IMAB 2014
- Country
- SPIR United States
- IMAB United States
- Employees
- SPIR N/A
- IMAB N/A
- Industry
- SPIR Telecommunications Equipment
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- SPIR Consumer Discretionary
- IMAB Health Care
- Exchange
- SPIR Nasdaq
- IMAB Nasdaq
- Market Cap
- SPIR 347.1M
- IMAB 394.2M
- IPO Year
- SPIR N/A
- IMAB 2020
- Fundamental
- Price
- SPIR $13.30
- IMAB $4.35
- Analyst Decision
- SPIR Strong Buy
- IMAB Strong Buy
- Analyst Count
- SPIR 4
- IMAB 6
- Target Price
- SPIR $16.75
- IMAB $7.17
- AVG Volume (30 Days)
- SPIR 509.8K
- IMAB 1.6M
- Earning Date
- SPIR 11-05-2025
- IMAB 11-02-2025
- Dividend Yield
- SPIR N/A
- IMAB N/A
- EPS Growth
- SPIR N/A
- IMAB N/A
- EPS
- SPIR N/A
- IMAB N/A
- Revenue
- SPIR $99,502,000.00
- IMAB N/A
- Revenue This Year
- SPIR N/A
- IMAB N/A
- Revenue Next Year
- SPIR $5.97
- IMAB N/A
- P/E Ratio
- SPIR N/A
- IMAB N/A
- Revenue Growth
- SPIR N/A
- IMAB N/A
- 52 Week Low
- SPIR $6.85
- IMAB $0.60
- 52 Week High
- SPIR $21.43
- IMAB $5.90
- Technical
- Relative Strength Index (RSI)
- SPIR 70.98
- IMAB 59.09
- Support Level
- SPIR $10.75
- IMAB $3.40
- Resistance Level
- SPIR $11.54
- IMAB $4.51
- Average True Range (ATR)
- SPIR 0.72
- IMAB 0.30
- MACD
- SPIR 0.29
- IMAB 0.06
- Stochastic Oscillator
- SPIR 82.21
- IMAB 85.59
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).